Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Accumulated Depreciation (2022 - 2025)

Historic Accumulated Depreciation for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $1.5 million.

  • Orchestra BioMed Holdings' Accumulated Depreciation rose 2698.93% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year increase of 2698.93%. This contributed to the annual value of $1.3 million for FY2024, which is 2480.84% up from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Accumulated Depreciation is $1.5 million, which was up 2698.93% from $1.5 million recorded in Q2 2025.
  • Orchestra BioMed Holdings' Accumulated Depreciation's 5-year high stood at $1.5 million during Q3 2025, with a 5-year trough of $778000.0 in Q4 2022.
  • Moreover, its 4-year median value for Accumulated Depreciation was $1.1 million (2024), whereas its average is $1.2 million.
  • In the last 5 years, Orchestra BioMed Holdings' Accumulated Depreciation soared by 3419.02% in 2023 and then soared by 2275.93% in 2024.
  • Over the past 4 years, Orchestra BioMed Holdings' Accumulated Depreciation (Quarter) stood at $778000.0 in 2022, then skyrocketed by 34.19% to $1.0 million in 2023, then grew by 24.81% to $1.3 million in 2024, then increased by 18.8% to $1.5 million in 2025.
  • Its last three reported values are $1.5 million in Q3 2025, $1.5 million for Q2 2025, and $1.4 million during Q1 2025.